Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia
Aligned Nanofibrillar Scaffolds Enhance Angiogenesis and Viability in Ischemia
批准号:
9208640
负责人:
Ngan F. Huang
金额:
$47.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-02-01 至 2021-01-31
关键词:
AddressAlpha CellAnatomyAngiographyAnimal ModelAnimalsApoptosisArterial Occlusive DiseasesArteriesBiocompatible MaterialsBiomimeticsBloodBlood VesselsBlood flowCell SurvivalCellsClinical TrialsCollagenCollagen FibrilCuesCultured CellsDataDevelopmentDisease modelElectrospinningEndothelial CellsEndotheliumExperimental ModelsFibrillar CollagenFluorescenceGangreneGoalsGrowth FactorHindlimbHistologicHumanHydrogelsHypoxiaImageImplantIn VitroInjectableIschemiaKineticsLasersLegLimb structureMechanicsMetabolicMethodsMindModelingNatural regenerationNitric OxidePainPatientsPeripheral arterial diseasePositron-Emission TomographyProcessProductionPropertyRecoveryReporterRoleSecondary toSignal TransductionSpectrum AnalysisStem cellsStructureTestingTissuesVascular blood supplyVascularizationX-Ray Computed Tomographyangiogenesisarmbasebioluminescence imagingblood perfusionclinical efficacyclinical translationclinically translatablecytokineendothelial dysfunctionimplantationimprovedin vivoinduced pluripotent stem celllimb amputationmigrationminimally invasivemouse modelnanopatternnanoscalenovel strategiesparacrinepublic health relevanceresponsescaffoldstem cell therapytreatment groupvascular endothelial dysfunction
中文摘要
描述(申请人提供):在美国,超过800万人患有外周动脉疾病(PAD),其特征是供应四肢血液的动脉变窄,导致组织缺血。PAD的一个中心特征是控制血管反应性和血管生成的血管内皮细胞(ECs)功能障碍。我们以前已经证明,人诱导多能干细胞(IPSC-ECs)来源的ECs可以改善PAD的实验模型--诱发后肢缺血动物的血液灌注量。然而,较差的细胞存活率限制了它们的血管生成潜力。为了解决这一限制,我们寻求开发排列的纳米纤维胶原支架,以模仿天然胶原纤维的卷曲(波状)结构。与缺乏有组织的纳米级结构和机械完整性的可注射支架相比,我们的初步数据表明,排列的纳米纤维支架为引导新形成的血管的组织、指导细胞生存和刺激血管生成提供了结构支持。全球假说是,卷曲排列的纳米纤维支架种植IPSC-ECs将提高细胞存活,加速血管网络的形成,并在大小动物PAD模型中诱导缺血肢体的血管生成。在这项重新提交的申请中,特定目标1将测试以下假设:与随机定向支架相比,卷曲排列的纳米纤维支架将在体外增强IPSC-EC的存活和血管生成。在长达14天的时间里,将定量比较种植在定向或随机定向支架上的IPSC-ECs在低氧(1%O2)下的细胞活性和血管生成(迁移、血管网络形成和细胞因子产生)。为了在体内验证这些发现,Special Aim 2将比较IPSC-EC种子定向纳米纤维支架植入缺血肢体后血管生成、动脉生成和细胞存活的时间过程。在28天内,细胞存活、血液灌流恢复和新微血管的形成将分别通过生物发光成像、激光多普勒血液光谱学和微型计算机断层成像来定量评估,这些细胞种植在定向或随机取向的支架上。对于临床翻译,特殊目标3将是一项探索性研究,在该研究中,种植在排列或随机取向支架上的IPSC-ECs将被植入到绵羊肢体缺血模型中。细胞存活情况将被追踪。微血管形成和血流灌注恢复的时间过程将分别通过计算机断层扫描和荧光辅助血管成像进行评估。将支架解剖隧道植入缺血肢体也将被视为一种临床可翻译的微创给药方法。总之,这些研究结果将导致仿生纳米纤维支架的开发,以提高干细胞治疗PAD患者的临床疗效。我们已经产生了初步的科学组成部分,并汇集了专业知识,希望能够成功实现这些目标。
英文摘要
DESCRIPTION (provided by applicant): Over 8 million people in the US suffer from peripheral arterial disease (PAD), which is characterized by narrowing of the arteries that supply blood flow to the limbs, leading to tissue ischemia. A central feature of PAD is dysfunction of the vascular endothelial cells (ECs) that control vascular reactivity and angiogenesis. We previously demonstrated that ECs derived from human induced pluripotent stem cells (iPSC-ECs) can improve blood perfusion in animals with induced hindlimb ischemia, an experimental model of PAD. However, poor cell survival limited their angiogenic potential. To address this limitation, we seek to develop aligned nanofibrillar collagen scaffolds that mimic the crimped (wavy) structure of native collagen fibrils. In comparison to injectable scaffolds, which lack organized nano-scale structure and mechanical integrity, our preliminary data suggests that aligned nanofibrillar scaffolds provide structural support for guiding the organization of newly formed vessels, directing cell survival, and stimulating angiogenesis. The global hypothesis is that crimped aligned nanofibrillar scaffolds seeded with iPSC-ECs will enhance cell survival, accelerate vascular network formation, and induce angiogenesis in the ischemic limb in small and large animal PAD models. In this resubmission application, Specific Aim 1 will test the hypothesis that crimped aligned nanofibrillar scaffolds, in contrast to randomly oriented scaffolds, will enhance iPSC-EC survival and angiogenesis in vitro. For up to 14 days, cell viability and angiogenesis (migration, vascular network formation, and cytokine production) will be quantitatively compared between iPSC-ECs that are seeded on aligned or randomly oriented scaffolds under hypoxia (1% O2). To validate these findings in vivo, Specific Aim 2 will compare the temporal process of angiogenesis, arteriogenesis, and cell survival after implantation of the iPSC-EC-seeded aligned nanofibrillar scaffold into the ischemic limb. Over 28 days, cell survival, blood perfusion recovery, and formation of new microvasculature will be quantitatively assessed by bioluminescence imaging, laser Doppler blood spectroscopy, and micro computed tomography imaging, respectively, between cells seeded on aligned or randomly oriented scaffolds. Towards clinical translation, Specific Aim 3 will be an exploratory study in which iPSC-ECs seeded on aligned or randomly oriented scaffolds will be implanted into an ovine limb ischemia model. Cell survival will be tracked by. The temporal process of microvessel formation and blood perfusion recovery will be assessed by computed tomography and fluorescence assisted angiography, respectively. Anatomical tunneling of the scaffolds to the ischemic limb will also be examined as a clinically translatable minimally invasive delivery approach. Together, the results of these studies will lead to the development of biomimetic nanofibrillar scaffolds to improve the clinical efficacy of stem cell therapy to PAD patients. We have generated the preliminary scientific components and assembled the expertise to hopefully successfully achieve these goals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10703808
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:Ngan F. Huang
-
依托单位:
Novel Highly Regenerative and Scalable Progenitor Cell Exosomes for Treating Peripheral Artery Disease
-
批准号:10759902
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2023
-
负责人:Ngan F. Huang
-
依托单位:
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss
-
批准号:10158427
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Ngan F. Huang
-
依托单位:
Engineering Vascularized Skeletal Muscle for Treatment of Volumetric Muscle Loss
-
批准号:10386908
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Ngan F. Huang
-
依托单位:
Muscle stem cell therapy for volumetric muscle loss
-
批准号:10284923
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Ngan F. Huang
-
依托单位:
Muscle stem cell therapy for volumetric muscle loss
-
批准号:10631859
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Ngan F. Huang
-
依托单位:
Matrix-mediated endothelial differentiation of induced pluripotent stem cells
-
批准号:8133483
-
项目类别:
-
资助金额:$13.28万
-
财政年份:2010
-
负责人:Ngan F. Huang
-
依托单位:
Matrix-mediated endothelial differentiation of induced pluripotent stem cells
-
批准号:8626434
-
项目类别:
-
资助金额:$24.4万
-
财政年份:2010
-
负责人:Ngan F. Huang
-
依托单位:
Matrix-mediated endothelial differentiation of induced pluripotent stem cells
-
批准号:7989804
-
项目类别:
-
资助金额:$13.28万
-
财政年份:2010
-
负责人:Ngan F. Huang
-
依托单位:
Matrix-mediated endothelial differentiation of induced pluripotent stem cells
-
批准号:8594408
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2010
-
负责人:Ngan F. Huang
-
依托单位:
High throughput screening of embryonic stem cell differentiation
-
批准号:7613572
-
项目类别:
-
资助金额:$5.17万
-
财政年份:2009
-
负责人:Ngan F. Huang
-
依托单位:
海外基金